Similar to other PROPEL implants, PROPEL Contour was studied in a prospective, randomized, blinded, controlled trial to evaluate its benefits following frontal sinus surgery. The 80-patient PROGRESS—PROPEL Contour study demonstrated reductions in the rate of occlusion as well as need for postoperative interventions compared to frontal sinus surgery alone.1,2
Contraindications include patients with intolerance to mometasone furoate (MF) or a hypersensitivity to bioabsorbable polymers. Safety and effectiveness of the implants in pregnant or nursing females have not been studied. Risks may include, but are not limited to, pain/pressure, displacement of implant, possible side effects of intranasal MF, sinusitis, epistaxis, and infection. Rx Only.